$50,000 of NOVAVAX INC. lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to federal vaccine programs and vaccine regulatory frameworks. FDA funding and advocacy H.R.4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026"

You can find more data on corporate lobbying on Quiver Quantitative.

NVAX Hedge Fund Activity

We have seen 106 institutional investors add shares of NVAX stock to their portfolio, and 91 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• COATUE MANAGEMENT LLC added 3,836,986 shares (+inf%) to their portfolio in Q1 2026, for an estimated $31,233,066
• MORGAN STANLEY removed 3,145,950 shares (-84.6%) from their portfolio in Q1 2026, for an estimated $25,608,033
• BANK OF AMERICA CORP /DE/ removed 1,653,452 shares (-19.9%) from their portfolio in Q1 2026, for an estimated $13,459,099
• POINT72 ASSET MANAGEMENT, L.P. added 1,501,776 shares (+9137.7%) to their portfolio in Q1 2026, for an estimated $12,224,456
• SG AMERICAS SECURITIES, LLC removed 835,303 shares (-85.6%) from their portfolio in Q1 2026, for an estimated $6,799,366
• HRT FINANCIAL LP removed 834,223 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $6,790,575
• JEFFERIES FINANCIAL GROUP INC. added 673,120 shares (+inf%) to their portfolio in Q1 2026, for an estimated $5,479,196

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

NVAX Analyst Ratings

Wall Street analysts have issued reports on $NVAX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 01/20/2026

To track analyst ratings and price targets for NVAX, check out Quiver Quantitative's $NVAX forecast page.

NVAX Price Targets

Multiple analysts have issued price targets for $NVAX recently. We have seen 3 analysts offer price targets for $NVAX in the last 6 months, with a median target of $16.0.

Here are some recent targets:

• Thomas Shrader from BTIG set a target price of $19.0 on 06/11/2026
• Chris LoBianco from TD Cowen set a target price of $9.0 on 05/06/2026
• Sean Lee from HC Wainwright & Co. set a target price of $16.0 on 02/27/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read full article here »